Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,127 | 260 | 98.6% |
| Education | $58.50 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $860.82 | 57 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $698.82 | 40 | $0 (2024) |
| PFIZER INC. | $441.19 | 42 | $0 (2023) |
| Janssen Biotech, Inc. | $296.69 | 20 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $250.43 | 8 | $0 (2024) |
| GENZYME CORPORATION | $197.62 | 9 | $0 (2024) |
| Lilly USA, LLC | $189.31 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $180.78 | 7 | $0 (2023) |
| MAYNE PHARMA INC. | $168.82 | 11 | $0 (2022) |
| LEO Pharma Inc. | $119.03 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $762.74 | 41 | Novartis Pharmaceuticals Corporation ($174.42) |
| 2023 | $372.79 | 20 | Novartis Pharmaceuticals Corporation ($110.93) |
| 2022 | $619.95 | 42 | Novartis Pharmaceuticals Corporation ($163.62) |
| 2021 | $203.94 | 13 | PFIZER INC. ($59.73) |
| 2020 | $170.50 | 11 | AbbVie Inc. ($42.51) |
| 2019 | $837.31 | 43 | AbbVie, Inc. ($279.62) |
| 2018 | $619.26 | 46 | AbbVie, Inc. ($169.19) |
| 2017 | $599.09 | 47 | PFIZER INC. ($110.31) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.75 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.11 | General |
| Category: Immunology | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.65 | General |
| Category: Immunology | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.05 | General |
| Category: Immunology | ||||||
| 10/09/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: DERMATOLOGY | ||||||
| 10/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: Dermatology | ||||||
| 09/27/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.93 | General |
| 09/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: DERMATOLOGY | ||||||
| 08/26/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.89 | General |
| 08/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Immunology | ||||||
| 08/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Dermatology | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Dermatology | ||||||
| 07/16/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 07/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Dermatology | ||||||
| 06/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 5,079 | 13,294 | $1.5M | $679,508 |
| 2022 | 34 | 4,886 | 13,674 | $1.7M | $746,831 |
| 2021 | 34 | 5,139 | 14,399 | $1.7M | $803,188 |
| 2020 | 38 | 5,096 | 13,909 | $1.5M | $732,209 |
All Medicare Procedures & Services
142 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 54 | 1,000 | $450,000 | $195,483 | 43.4% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 56 | 1,049 | $157,350 | $125,781 | 79.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 988 | 1,229 | $122,900 | $68,299 | 55.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 941 | 1,158 | $127,380 | $42,180 | 33.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 233 | 328 | $114,800 | $33,719 | 29.4% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 53 | 957 | $53,592 | $28,432 | 53.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 328 | 362 | $54,300 | $28,406 | 52.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 770 | 5,281 | $132,025 | $23,009 | 17.4% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 48 | 133 | $37,905 | $19,281 | 50.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 146 | 185 | $31,450 | $12,552 | 39.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 191 | 201 | $32,160 | $11,881 | 36.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 87 | 114 | $29,640 | $11,436 | 38.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 223 | 223 | $25,645 | $9,750 | 38.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 110 | 110 | $17,600 | $7,594 | 43.1% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 100 | 114 | $18,240 | $7,471 | 41.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 177 | 187 | $14,025 | $6,515 | 46.5% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 70 | 78 | $13,650 | $5,541 | 40.6% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 39 | 41 | $13,284 | $5,304 | 39.9% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 31 | 73 | $8,614 | $4,506 | 52.3% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 32 | 34 | $9,690 | $3,634 | 37.5% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 24 | 26 | $7,670 | $3,589 | 46.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 16 | 18 | $8,460 | $3,226 | 38.1% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 48 | 50 | $6,600 | $2,452 | 37.1% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 23 | 25 | $5,250 | $2,295 | 43.7% |
| 77261 | Simple radiation therapy planning | Office | 2023 | 40 | 42 | $8,820 | $2,261 | 25.6% |
About Dr. Alan Tanenbaum, M.D
Dr. Alan Tanenbaum, M.D is a Dermatology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114023611.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Tanenbaum, M.D has received a total of $4,186 in payments from pharmaceutical and medical device companies, with $762.74 received in 2024. These payments were reported across 263 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,127).
As a Medicare-enrolled provider, Tanenbaum has provided services to 20,200 Medicare beneficiaries, totaling 55,276 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 142 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Memphis, TN
- Active Since 09/15/2006
- Last Updated 03/08/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1114023611
Products in Payments
- EUCRISA (Drug) $441.19
- COSENTYX (Biological) $398.21
- Humira (Biological) $357.79
- COSENTYX (Drug) $285.35
- SKYRIZI (Biological) $278.31
- DUPIXENT (Biological) $249.51
- ILUMYA (Biological) $216.31
- TALTZ (Drug) $189.31
- DORYX (Drug) $153.69
- REMICADE (Biological) $152.88
- Skyrizi (Biological) $117.46
- DUPIXENT DUPILUMAB INJECTION (Biological) $91.82
- ADBRY (Biological) $76.65
- Sotyktu (Drug) $75.56
- VTAMA (Drug) $74.40
- Tremfya (Drug) $71.39
- Olux (Drug) $64.85
- Finacea (Drug) $63.97
- RINVOQ (Biological) $60.05
- HUMIRA (Biological) $47.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Memphis
Dr. Emily Overholser, M.d, M.D
Dermatology — Payments: $253,001
Dr. Sarah Smith, M.d, M.D
Dermatology — Payments: $80,240
Robert Kaplan, Md, MD
Dermatology — Payments: $17,611
Dr. Alan Levy, M.d, M.D
Dermatology — Payments: $15,231
Dr. Alexandra Chantara, M.d, M.D
Dermatology — Payments: $4,057
Dr. Whitney Shroyer, M.d, M.D
Dermatology — Payments: $1,711